Laura Asinas Blackburn

Laura Asinas Blackburn, JD, currently serves as Vice President and Head of Regulatory Affairs at Astria Therapeutics, Inc. since April 2022. Prior experience includes roles such as Executive Director and Senior Director of Regulatory Affairs and Quality Assurance at Morphic Therapeutic from May 2019 to April 2022. Blackburn has also worked as an Independent Regulatory Consultant for various companies, including Proteon Therapeutics, Verastem Oncology, Inotek Pharmaceuticals Corporation, NKT Therapeutics Inc., Sideris Pharmaceuticals, Infinity Pharmaceuticals, and Foldrx Pharmaceuticals, with consulting roles spanning from November 2008 to 2019. Blackburn holds a Juris Doctor from Western New England University School of Law and a Bachelor of Arts in Psychology from Wellesley College.